Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

by Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, John H. Stone, John H. Stone, John H. Stone
Published 2019-12-01

Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease

by Hamid Mattoo, John H. Stone, Shiv Pillai
Published 2017-01-01

Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial

by Naomi J. Patel, Xiaoqing Fu, Yuqing Zhang, John H. Stone
Published 2023-01-01

Development of an IgG4-RD Responder Index

by Mollie N. Carruthers, John H. Stone, Vikram Deshpande, Arezou Khosroshahi
Published 2012-01-01

Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial

by Neil Collinson, Katie Tuckwell, Frank Habeck, Monique Chapman, Micki Klearman, John H. Stone
Published 2015-01-01

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

by Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John H. Stone
Published 2019-02-01

IgG4-Related Disease

by John H. Stone, John K. C. Chan, Vikram Deshpande, Kazuichi Okazaki, Hisanori Umehara, Yoh Zen
Published 2013-01-01

Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End‐Stage Renal Disease in the US Renal Data System

by Claire E. Cook, Xiaoqing Fu, Yuqing Zhang, John H. Stone, Hyon K. Choi, Zachary S. Wallace
Published 2022-01-01

Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic

by Claire Cook, Huel Cox, Xiaoqing Fu, Yuqing Zhang, John H. Stone, Hyon K. Choi, Zachary S. Wallace
Published 2021-12-01

Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis

by Zachary S. Wallace, Tyler Harkness, Kimberly G. Blumenthal, Hyon K. Choi, John H. Stone, Rochelle P. Walensky
Published 2020-05-01

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor

by Arezou Khosroshahi, Rivka Ayalon, Laurence H. Beck, David J. Salant, Donald B. Bloch, John H. Stone
Published 2012-01-01

Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data

by Zachary S. Wallace, Xiaoqing Fu, Claire Cook, Cory A. Perugino, Yuqing Zhang, John H. Stone, Hyon K. Choi
Published 2022-04-01

Design of the Tocilizumab in Giant Cell Arteritis Trial

by Sebastian H. Unizony, Bhaskar Dasgupta, Elena Fisheleva, Lucy Rowell, Georg Schett, Robert Spiera, Jochen Zwerina, Olivier Harari, John H. Stone
Published 2013-01-01

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

by Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood, Shalini V. Mohan
Published 2019-02-01

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

by Sebastian Unizony, Timothy J. McCulley, Robert Spiera, Jinglan Pei, Paris N. Sidiropoulos, Jennie H. Best, Christine Birchwood, Andrey Pavlov, John H. Stone
Published 2021-01-01

Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report

by Denis T. Balaban, Spencer K. Hutto, Bruno P. Panzarini, Aileen O'Shea, Aditi Varma, Pamela S. Jones, Bart K. Chwalisz, Bart K. Chwalisz, John H. Stone, Nagagopal Venna
Published 2023-05-01

Pulmonary and coronary arterial abnormalities in patients with IgG4-related disease

by Rory L. Cochran, MD, PhD, Holly R. Brideau, MD, MS, Markus Y. Wu, MD, John H. Stone, MD, MPH, Zachary S. Wallace, MD, MSc, Brent P. Little, MD
Published 2022-12-01

Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary

by Yicong Liang, MD, Faith A.P. Zeng, Tabrez Sheriff, MD, Anna Wilson, MD, Asli Bilgic, MD, Grant Feng, John H. Stone, MD, MPH, Dedee F. Murrell, MA, BMBCh, MD
Published 2022-03-01

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

by Cory Perugino, Emma L. Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, Nicolas Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H. Stone
Published 2023-10-01

Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis

by Damian R. Plichta, Juhi Somani, Matthieu Pichaud, Zachary S. Wallace, Ana D. Fernandes, Cory A. Perugino, Harri Lähdesmäki, John H. Stone, Hera Vlamakis, Daniel C. Chung, Dinesh Khanna, Shiv Pillai, Ramnik J. Xavier
Published 2021-02-01